年龄相关肌肉骨骼疾病与帕金森病的关联:英国生物银行队列研究
基于英国生物银行362 656名参与者(平均年龄56.48岁,中位随访13.65年)的队列研究显示,肌少症和骨质疏松分别与帕金森病风险升高独立相关,且风险随年龄相关肌肉骨骼疾病数量增加而升高;神经影像分析提示这些疾病与广泛脑结构改变相关。
要点
- 肌少症(HR 1.74)和骨质疏松(HR 1.76)分别与帕金森病风险升高独立相关。
- 帕金森病风险随年龄相关肌肉骨骼疾病数量增加而升高(HR 1.30,趋势P<.001)。
- 年龄相关肌肉骨骼疾病诊断后5年内帕金森病诊断比值比最高(OR 2.19)。
核心结论
- 年龄相关肌肉骨骼疾病与帕金森病风险升高及脑结构改变相关,针对肌肉骨骼健康的干预可能有助于维持内在能力并延缓或预防帕金森病。
研究设计与样本
- 基于英国生物银行362 656名参与者的前瞻性队列研究,平均年龄56.48岁,中位随访13.65年,采用Cox模型、巢式病例对照分析和多变量回归分析。
主要发现
- 随访期间2057名参与者发生帕金森病。
- 肌少症与帕金森病风险升高独立相关(HR 1.74,95%CI 1.45-2.08,P<.001)。
- 骨质疏松与帕金森病风险升高独立相关(HR 1.76,95%CI 1.34-2.32,P<.001)。
- 帕金森病风险随年龄相关肌肉骨骼疾病数量增加而升高(HR 1.30,95%CI 1.19-1.41,趋势P<.001)。
- 年龄相关肌肉骨骼疾病诊断后5年内帕金森病诊断比值比最高(OR 2.19,95%CI 1.59-2.96,P<.001)。
关键数值与推荐
- 肌少症:HR 1.74(95%CI 1.45-2.08,P<.001)。
- 骨质疏松:HR 1.76(95%CI 1.34-2.32,P<.001)。
- 年龄相关肌肉骨骼疾病数量累积:HR 1.30(95%CI 1.19-1.41,趋势P<.001)。
- 年龄相关肌肉骨骼疾病诊断后5年内帕金森病诊断:OR 2.19(95%CI 1.59-2.96,P<.001)。
临床怎么用
- 对老年肌少症或骨质疏松患者,应关注帕金森病相关运动和非运动症状,尤其在诊断后5年内。
- 评估和管理肌肉骨骼健康可能作为维持内在能力、降低帕金森病风险的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Age-related musculoskeletal diseases (ARMDs), including sarcopenia, osteoporosis, and osteoarthritis, may contribute to declines in intrinsic capacity and co-occur with neurodegenerative disorders such as Parkinson disease (PD). We examined the association between ARMDs and PD risk. METHODS: In 362 656 UK Biobank participants (mean age: 56.48 years; median follow-up 13.65 years), ARMDs were assessed individually and cumulatively. Cox models estimated PD risk, adjusting for demographic, lifestyle, and genetic factors. Subgroup and sensitivity analyses were conducted to ensure robustness. A nested case-control analysis further explored the relationship between the duration of ARMDs exposure and the odds of PD diagnosis. Multivariable regression models assessed the associations between ARMDs and brain structure, including cortical, gray matter, and white matter integrity. RESULTS: During follow-up, 2057 participants developed PD. Sarcopenia (hazard ratio [HR]: 1.74, 95% confidence interval [CI]: 1.45-2.08, p < .001) and osteoporosis (HR: 1.76, 95% CI: 1.34-2.32, p < .001) were independently associated with higher PD risk. PD risk increased with the number of ARMDs (HR: 1.30, 95% CI 1.19-1.41; ptrend < .001) and the odds of PD diagnosis was highest within 5 years of the ARMDs diagnosis (odds ratio [OR] 2.19, 95% CI: 1.59-2.96, p < .001). Neuroimaging analysis indicated that ARMDs were associated with widespread and significant brain structural alterations, including in regions related to motor control. CONCLUSIONS: ARMDs are linked to elevated PD risk and brain structural changes. Interventions targeting musculoskeletal health may help preserve intrinsic capacity and delay or prevent PD onset in aging populations.
引用
- Yang T, Huang J, Xiao Y, et al. Association between age-related musculoskeletal diseases and Parkinson disease: a population-based cohort study of UK Biobank. J Gerontol A Biol Sci Med Sci. 2026. PMID: 42249707. doi:10.1093/gerona/glag151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。